ClinicalTrials.gov
public full text
Public Domain
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
This research study is being done to determine the rate of testosterone recovery after completing two years of treatment with the combination of relugolix and darolutamide as well as to assess the safety of the drugs when administered in combination. The names of the drugs in this study are: * Relugolix (a type of gonadotropin-releasing hormone receptor antagonist) * Darolutamide (a type of androgen receptor antagonist)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).#1046099
- AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment#890812
- Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression#1007434
- Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence#1127295
- Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer#883207
Record · ID 1152415
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive